Lifeboat Foundation

ABS is partnering with Telemedia, a broadcasting and teleport service provider in South Africa, to improve its service offerings to customers in the Middle East and Africa region (MEA). ABS announced Monday that the company will gain access to a full suite of telecom services provided by Telemedia at its Johannesburg teleport. Telemedia will provide teleport fiber connectivity, data center hosting, and satellite uplink capabilities.

Telemedia said the partnership enables the company to further expand its broadcast and satellite connectivity services in the MEA.

“Our collaboration with Telemedia reinforces and strengthens our presence in the MEA and provides an extension to our global connectivity network,” Ron Busch, ABS’ EVP Engineering and Operations said. “[Telemedia’s] infrastructure offering with a solid track record, excellent customer support and can-do attitude during the COVID-19 pandemic shows its commitment to excellent customer service.”

Given a large volume of spoken or written speech, can you tease out a signal?

A first patient has been dosed in IMAC Holdings’ Phase 1 clinical trial evaluating its investigational umbilical cord-derived mesenchymal stem cells (MSCs) as a potential treatment for bradykinesia, a common motor symptom of Parkinson’s disease.

The infusion treatment was given on Dec. 292020, by the trial’s lead investigator Ricardo Knight, MD, at IMAC’s facility in Brentwood, Tennessee, the company announced.

These new, adaptive stem cells can lie dormant until needed, a new animal study using human cells shows.

A new type of stem cell – that is, a cell with regenerative abilities – could be closer on the horizon, a new study led by UNSW Sydney shows.

Continue reading “A Step Closer to Developing ‘Smart’ Stem Cells – Cells With Regenerative Abilities – Made From Human Fat” »

One common symptom of multiple sclerosis (MS) is vision impairment, and it can progress to blindness in some cases. Now, researchers at the University of California, Riverside (UCR) report a drug that was able to reverse that vision loss in mice.

Microfluidic device sheds light on how short-chain fatty acids produced by gut bacteria may influence neurological diseases.

MIT study sheds light on the longstanding question of why cancer cells get their energy from fermentation.

In the 1920s, German chemist Otto Warburg discovered that cancer cells don’t metabolize sugar the same way that healthy cells usually do. Since then, scientists have tried to figure out why cancer cells use this alternative pathway, which is much less efficient.

MIT biologists have now found a possible answer to this longstanding question. In a study appearing in Molecular Cell, they showed that this metabolic pathway, known as fermentation, helps cells to regenerate large quantities of a molecule called NAD+, which they need to synthesize DNA and other important molecules. Their findings also account for why other types of rapidly proliferating cells, such as immune cells, switch over to fermentation.

A mitochondrial hormone expressed by cells deep in the brain appears to play a role in improving metabolism and fighting off obesity, according to a new study in mice.

Formic ventures — taking on huge challenges — from virtual reality technologist to longevity biotechnology investor.

Michael Antonov is the Founder and CEO of The Michael Antonov Foundation (https://antonovfoundation.org/), a charitable organization that supports biotechnology research and various causes that improve well being of people around the world, as well as Formic Ventures (https://formic.vc/index.html), an early stage high tech and biotech investment firm focused on prolonging human healthspan and empowering human creativity.

Continue reading “Michael Antonov — Formic Ventures — Taking On Huge Challenges — From VR To Longevity Biotechnology” »